No photo of Ivo L Abraham

View Scopus Profile

Ivo L Abraham

  • 5754 Citations
  • 36 h-Index
1982 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ivo L Abraham is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

NURSING TREATMENTS FOR DEPRESSED AGED IN LONG TERM CARE

Abraham, I. L.

National Institutes of Health

3/1/87 → 2/28/89

Project: Research project

BIOMEDICAL RESEARCH SUPPORT GRANT

Abraham, I. L., Morrision, E., Kiley, M., Krowchuk, H., Youngblut, J., Workman, L., Roberts, B. & Fitzpatrick, J.

National Institutes of Health

4/1/85 → 9/29/92

Project: Research project

    • Research Output

    Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1

    Nguyen, L., Zhang, X., Roberts, E., Yun, S., McGraw, K., Abraham, I., Song, J., Braswell, D., Qin, D., Sallman, D. A., Lancet, J. E., List, A. F., Moscinski, L. C., Padron, E. & Zhang, L., May 11 2020, In : Leukemia and Lymphoma. 61, 6, p. 1395-1405 11 p.

    Research output: Contribution to journal › Article

    • Economic modeling for the US of the cost-efficiency and associated expanded treatment access of conversion to biosimilar pegfilgrastim-bmez from reference pegfilgrastim

    McBride, A., Wang, W., Campbell, K., Balu, S., MacDonald, K. & Abraham, I., Jan 1 2020, (Accepted/In press) In : Journal of medical economics.

    Research output: Contribution to journal › Article

    Open Access

    • Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis

    Alhifany, A. A., McBride, A., Almutairi, A. R., Cheema, E., Shahbar, A., Alatawi, Y., Alharbi, A. S., Babiker, H., MacDonald, K., Aapro, M. & Abraham, I., Mar 1 2020, In : Supportive Care in Cancer. 28, 3, p. 1031-1039 9 p.

    Research output: Contribution to journal › Review article

    • Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis

    Alkhushaym, N., Almutairi, A. R., Althagafi, A., Fallatah, S. B., Oh, M., Martin, J. R., Babiker, H. M., McBride, A. & Abraham, I., Mar 3 2020, In : Expert Opinion on Drug Safety. 19, 3, p. 327-334 8 p.

    Research output: Contribution to journal › Article

    • Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma

    McBride, A., Krendyukov, A., Mathieson, N., Campbell, K., Balu, S., Natek, M., MacDonald, K. & Abraham, I., Jan 2 2020, In : Journal of medical economics. 23, 1, p. 28-36 9 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations